Year in Review: Physicians Pick the Biggest News of 2019
Check out TCTMD’s interactive feature exploring the biggest news impacting cardiology this year, chosen by experts across subspecialties.
Check out TCTMD’s interactive feature exploring the biggest news impacting cardiology this year, chosen by experts across subspecialties.
CCCTN registry data reinforce the message that DanGer Shock’s findings supporting MCS apply narrowly to patients studied.
Surviving a SARS-CoV-2 infection may be a reason to be more vigilant about general CV prevention measures moving forward.
The experts provide a how-to on dealing with sticky situations, such as no-flow and large thrombus, during PCI for STEMI.
The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.
Whether to use ATP is not clear-cut and the choice should be made through shared decision-making, one expert says.
The data shed more light on how patients in the real world are faring after CAR T-cell treatment, says Sarju Ganatra.
Masahiro Natsuaki and C. Michael Gibson discuss this latest randomized comparison of prasugrel monotherapy and DAPT with aspirin for patients undergoing PCI.
To slow or reverse the trend, there needs to be a greater focus on primary prevention, Valery Feigin says.
The interconnection is far deeper than previously thought, raising new ways to promote health, says Fernando Testai.
A study reinforces the importance of supporting the arm and placing the BP cuff at heart level, as guidelines recommend.